Despite its widespread prevalence and association with several significant human diseases, including cancer and autoimmune disorders, there is currently no licensed vaccine to prevent Epstein-Barr Virus (EBV) Market infection, and treatment options for many EBV-related conditions remain limited to supportive care. However, ongoing research is actively pursuing the development of effective...